Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



libin cardiovascular institute of alberta1 - severe kyphoscoliosis1 - urologist1 - nephrolithotomy1 - autosomal-dominant polycystic kidney disease2 - genetic factors1 - renal function2 - renal vasoconstriction1 - overhydration1 - urs1 - fallopian tubes1 - risk of diabetes1 - trisomy1 - psa velocity1 - prostate cancer test1 - external sphincter dyssynergia1 - urinary drainage1 - antibiotic resistance1 - dietary phosphate2 - myocardial infarction1 - systems biology1 - nephron-sparing surgery1 - physician communication1 - prostate cancer etiology1 - carcinoma1 - robotic-assisted surgery1 - urinary sulfate2 - moderate incontinence1 - pelvic irradiation1 - symptomatic kidney stones1 -